FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
EDEX
alprostadil
LOE Approaching
INJECTION · INJECTABLE
erectile dysfunction due to neurogenicvasculogenic+2
1997
NDA
30/100
EFFEXOR
venlafaxine hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET
Anxiety
1993
NDA
30/100
EFFEXOR XR
venlafaxine hydrochloride
LOE Approaching
Viatris (2)
ORAL · CAPSULE, EXTENDED RELEASE
Anxiety
1997
NDA
30/100
EFFIENT
prasugrel hydrochloride
LOE Approaching
ORAL · TABLET
thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndromenon-ST-elevation myocardial infarction (NSTEMI) ( )+2
2009
NDA
30/100
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: runny nose itchy+2
1994
NDA
30/100
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
nasal congestion due to the common coldhay fever+3
1996
NDA
30/100
EFUDEX
fluorouracil
LOE Approaching
TOPICAL · CREAM
1970
NDA
30/100
ELAVIL
amitriptyline hydrochloride
LOE Approaching
AstraZeneca
INJECTION · INJECTABLE
depression
1961
NDA
30/100
ELAVIL
amitriptyline hydrochloride
LOE Approaching
AstraZeneca
ORAL · TABLET
depression
1961
NDA
30/100
ELDEPRYL
selegiline hydrochloride
LOE Approaching
ORAL · CAPSULE
1996
NDA
30/100
ELESTAT
epinastine hydrochloride
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
itching associated with allergic conjunctivitis
2003
NDA
30/100
ELESTRIN
estradiol
LOE Approaching
Viatris (2)
TRANSDERMAL · GEL, METERED
2006
NDA
30/100
ELIDEL
pimecrolimus
LOE Approaching
Bausch + Lomb
TOPICAL · CREAM
atopic dermatitis
2001
NDA
30/100
ELIMITE
permethrin
LOE Approaching
TOPICAL · CREAM
infestation with Sarcoptes scabiei (scabies)
1989
NDA
30/100
ELLENCE
epirubicin hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
breast cancer
1999
NDA
30/100
ELLIOTTS B SOLUTION
sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
LOE Approaching
INTRATHECAL · INJECTABLE
leukemialymphoma
1996
NDA
30/100
ELMIRON
pentosan polysulfate sodium
LOE Approaching
Johnson & Johnson
ORAL · CAPSULE
1996
NDA
30/100
ELOCON
mometasone furoate
LOE Approaching
Merck & Co.
TOPICAL · CREAM
1987
NDA
30/100
ELOCON
mometasone furoate
LOE Approaching
Merck & Co.
TOPICAL · OINTMENT
1987
NDA
30/100
ELOCON
mometasone furoate
LOE Approaching
Merck & Co.
TOPICAL · LOTION
1989
NDA
30/100
ELOXATIN
oxaliplatin
LOE Approaching
Sanofi
INTRAVENOUS · INJECTABLE
colorectal cancer
2002
NDA
30/100
EMADINE
emedastine difumarate
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
1997
NDA
30/100
EMCYT
estramustine phosphate sodium
LOE Approaching
Pfizer
ORAL · CAPSULE
1981
NDA
30/100
EMEND
fosaprepitant dimeglumine
LOE Approaching
Merck & Co.
INTRAVENOUS · POWDER
older for the prevention of: acutedelayed nausea+5
2008
NDA
30/100
← PreviousPage 57 of 188Next →